Clinical Trial Update: Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjunctive celecoxib for bipolar postpartum depression was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Postpartum Depression

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Bipolar Disorder, Postpartum Depression | Phase 3 | Status: TERMINATED